2019 CRI Meeting Abstracts

Strategies to Maximize Innovation to Advance Cancer Clinical Research

The 11th Annual AACI CRI Meeting theme will focus on strategies to maximize innovation to advance cancer clinical research. The purpose of the abstracts is to inform meeting attendees about clinical trials office challenges and solutions implemented at AACI cancer centers. This year, CRI received 66 abstracts and saw an increase in partnerships between cancer centers and other organizations.

Three abstracts will be selected for oral presentation at the meeting. Up to two authors of each winning abstract will receive complimentary meeting registration or a refund for a previously paid meeting registration fee. While AACI encourages collaboration with external organizations, only employees of AACI member cancer centers are eligible for complimentary meeting registration.

All abstract authors are invited to present a poster and discuss their findings during the poster session at the meeting. More information can be found below in the Poster Session FAQ. 
 
Abstracts are organized into the following predefined categories:
 
Categories:
Clinical Research Operations
Finance/CCSG/PRMS
Investigator-Initiated Trials
Regulatory
Training and Quality Assurance
Trial Recruitment and Disparities Research
Trial Startup/Closure


Submitted abstracts are organized by category, in alphabetical order by cancer center.

Clinical Research Operations

Multifunctional Staff Focus Groups as a Tool to Improve Employee Engagement of Clinical Trials Office Staff [Abstract]
L. Lange, S. Bigelow, C. Brown, P. Dykema, D. Erickson, L. Jakovski
Barbara Ann Karmanos Cancer Institute, Wayne State University

THAW – The Holistic Approach for Working in Cellular and Gene Therapy Clinical Trials [Abstract
J. Gould, K. Shrestha, R. McCray, F. Brogan, D. Otap, M. Kelsen, M. Mapara, R. Reshef, A. Lassman
Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center

Implementation of an Oncology Clinical Research Merit-Based Recognition Program for Physicians [Abstract]
T. Adrales Bentz, C. Britten, D. Berrier, D. Marshall
Hollings Cancer Center, Medical University of South Carolina

Full Integration of the Gynecology Oncology Research Operations Under the IU Simon Cancer Center Clinical Trials Office [Abstract]
M. Contreraz, S. Edwards, L. Vaughn, K. Miller
Indiana University Melvin & Bren Simon Cancer Center

Developing an Automated Deviation Reporting and Electronic PI Attestation Process [Abstract]
L. Rohn, J. Nichols, A. Semla, S. Asche, J. Leiriao
Indiana University Melvin & Bren Simon Cancer Center

Development of a Systematic Review of Molecular Testing Increases Precision Medicine Based Clinical Trial Screening and Awareness [Abstract
M. Lasowski, B. George, B. Oleson, J. Thomas
Medical College of Wisconsin Cancer Center

Electronic Informed Consent (eIC) Platform for Clinical Trials: An Operational Model and Suite of Tools for Consent Authoring, Obtaining Informed Consent, and Managing Consent Documents [Abstract
J. Lengfellner, M. Buckley, M. Koch, H. Pacheco, J. Levine, C. Hoidra, D. Damron, C. Houston, R. Cambria, A. Rodavitch, P. Sabbatini, E. Cottington
Memorial Sloan Kettering Cancer Center

Reducing Overhead During Study Startup With System Integrations [Abstract]
N. VanKuren1, R. Jones2, A. Garcia2
1Sidney Kimmel Cancer Center at Jefferson Health; 2Florence Healthcare

Connecting the Supply Chain [Abstract]
D.P. Mudaranthakam1, J. Thompson1, J. McIlwain2
1The University of Kansas Cancer Center; 2Velos

Creating a Clinical Research Network [Abstract]
A. Yost, L. Curran, A. Skafel, M. Feng, E. Small
UCSF Helen Diller Family Comprehensive Cancer Center

Data Analytics on Data Reporting: Building on Current Tools to Transform Available Data Into Useful Tools [Abstract]
K. Cha, A. Skafel, M. Kock, E. Pon
UCSF Helen Diller Family Comprehensive Cancer Center

Building a Clinical Career Ladder [Abstract
S. Belanger, S. Ladd
UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Deployment of a Cancer Population Science Clinical Research Navigator to Improve Engagement With CPS Investigators [Abstract
A. Anderson, A. Ivey, T. George
University of Florida Health Cancer Center

A Data Informed Approach to Staffing Using OnCore [Abstract
L. Pettiford, A. Ivey, H. Koranne, W.J. Stokes, T. George
University of Florida Health Cancer Center

Institutional Perspectives on Cancer Community Activation Timelines [Abstract]
S. Stewart1, W. Tate2, L. Hilty2
1University of Wisconsin Carbone Cancer Center; 2Forte Research Systems

A Task-Based Automated Comprehensive Assessment Tool for Clinical Trial-Associated Workload [Abstract]
J. Plassmeyer, D. Cleary, C. Muniz, B. Crocker, K. Yee, K. Richter, B. Pappu
UPMC Hillman Cancer Center

Creating the Standard for Specialized Nurse Training in the Phase I Clinical Trials Setting [Abstract]
C. Belmore, J. Bourgeois, J. Warren, C. Lewis, R.D. Harvey, T. Mann
Winship Cancer Institute of Emory University

Designing a Phase I Clinical Trial Unit: A Multidisciplinary Collaborative Approach [Abstract
C. Lewis1, A. Kim2, M. Childress1, T.K. Owonikoko1, M.A. Bilen1, B. El-Rayes1, J. Bourgeois1, H. Collins1, C. Belmore1, T. Williams1, J. Warren1, M. Goodman1, K. Culver1, M. Williams1, E. Barton-Judson1, S. John, R.D. Harvey1
1Winship Cancer Institute of Emory University; 2Simpler Consulting, an IBM Company

Implementation and Application of the Ontario Protocol Assessment Level Tool at the Helen Diller Family Comprehensive Cancer Center [Abstract]
M. Kock, C. Aoun, K. Cha, A. Skafel
UCSF Helen Diller Family Comprehensive Cancer Center

Back to top

Finance/CCSG/PRMS

CTO Financial Dashboard [Abstract
A. Bowler, E. Bake, C. Ross
Huntsman Cancer Institute, University of Utah

What’s in a Pre-Review? Establishing a Streamlined Method for Ensuring Quality Submissions to Protocol Review Committees [Abstract
J. Migliacci, A. McKeown, A. Motta, D. Diaz-Leyton, C. Kolenut, X. Lekperic, K. Napolitano, C. Ryan, S. Hanley, A. Rodavitch
Memorial Sloan Kettering Cancer Center

Re-Envisioning Memorial Sloan Kettering’s Data and Safety Monitoring Committee [Abstract]
X. Lekperic, K. Napolitano, S. Hanley, C. Kolenut, A. Rodavitch, C. Houston, E.M. O'Reilly
Memorial Sloan Kettering Cancer Center

Enhancing the Capture of Oncology Study Activity via Scientific Review and IRB Collaboration [Abstract]
A. Anderson, T. George, MD, FACP, A. Ivey
University of Florida Health Cancer Center

Establishment of a Zero Tolerance Policy to Eliminate Non-Performing Studies [Abstract]
T. George, A. Ivey, A. Anderson, T. Guinn
University of Florida Health Cancer Center

Back to top

Investigator-Initiated Trials

Investigator-Initiated Trial Activation: Increasing Collaboration With a Protocol Navigator [Abstract]
K. Thorne
Huntsman Cancer Institute, University of Utah

Multicenter Investigator-Initiated Trial Prioritization [Abstract]
L. Sego, A. Bauchle, M. Darling, K. Miller, P. Loehrer, S. Farag, S. Edwards
Indiana University Melvin & Bren Simon Cancer Center

Implementation of a Concept Development Program for Investigator-Initiated Trials [Abstract]
A. Ivey A. Daniels, T. George
University of Florida Health Cancer Center

Back to top

Regulatory

SOP Implementation for Managing CIRB Studies in Data Analysis Only Status [Abstract]
S. Edwards, B. Johnson, I. SerVaas
Indiana University Melvin & Bren Simon Cancer Center

How to Implement a Master Delegation of Authority Process Across a Clinical Trials Office [Abstract]
L. Rohn, T. Detty, A. Semla, S. Asche, K. Ackerman
Indiana University Melvin & Bren Simon Cancer Center

Driving Innovation Through Regulatory and Product Development Magic [Abstract]
R. Ellis, S. Oliver, L. Shrestha, A. Yadav, O. Hauke;
Memorial Sloan Kettering Cancer Center

Overcoming the Burden of Paper Regulatory Binders Through eReg and eSignature Implementation [Abstract]
A. Green, M. Brown, K. Linsenmeyer, J. Gonzalez
The Ohio State University Comprehensive Cancer Center, James Cancer Hospital & Solove Research Institute

GOING LIVE With an e-Regulatory System: Lessons Learned in Managing the Change Process During an e-Regulatory Rollout at a Comprehensive Cancer Center [Abstract]
A. Drawz1, K. Akula1, C. Passaglia1, M. Hurley2
1Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 2Complion, Inc.

Back to top

Training and Quality Assurance

The Elephant in the Room – Onboarding of New Staff in an Evolving Research Landscape Plagued by Turnover [Abstract]
D. Farhat, J. Ventimiglia, E. Horvat, L. Casetta, J. Mancini
Barbara Ann Karmanos Cancer Institute, Wayne State University

Interactive Web-Based Imaging Response Assessment Training Application for Cancer Clinical Trials [Abstract
T. Urban, E. Ziegler, B. Somarouthu, D. Rukas, M. Leary, E. Correa, G. Basinsky, A. Van den Abbeele, G. Harris 
Dana-Farber Cancer Institute, Harvard Medical School

Risk-Based Monitoring as a Mechanism to Inform DSMC Practices [Abstract
T. Negri, D. Otap, M. Kelsen, F. Brogan, L. Blumberg, S. Kelly, J. Wang, M. Galazyn, J. Jurcic
Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center

How to Be a Principal Investigator: A Practical Training Program for Investigators [Abstract]
R. Kingsford, D. Pitt, S. Low, L. Weaver, J. Moehle, A. Cohen, T. Werner 
Huntsman Cancer Institute, University of Utah

Increasing Minority Oncology REpresentation (MORE) in Clinical Trials [Abstract]
S. Milescu, L. Vaughn, A. Al-Hader, S. Rawl, M. Contreraz, K. Miller
Indiana University Melvin & Bren Simon Cancer Center

The Case for a Designated Clinical Research Educator [Abstract
M. Gray, R. Selle, B. Oleson, J. Thomas
Medical College of Wisconsin Cancer Center

Developing a Standardized Library of Informed Consent Language to Ensure Consistency and Quality Across Clinical Trials at a Large Academic Medical Center [Abstract]
S. Briggs, C. Hoidra, D. Massengill, K. Rolla, R. Cambria, C. Houston, A. Rodavitch
Memorial Sloan Kettering Cancer Center

Standardization and Unification of Deficiency Language in Auditing and Monitoring [Abstract]
M. McGinn, K. Yataghene
Memorial Sloan Kettering Cancer Center

Using Centralized Review of Queries to Improve Data Integrity, a Canadian Clinical Trials Perspective [Abstract]
A. Goyal, E. Strom, S. Duric, S. Pardhan, S. Mulumba, J.M. Veigas, D. Gutierrez, R. Yogananthan, T. Jayasinghe, K. Sabate, M. Kirchmeyer, M. Artemakis, A. Topalovich, L. Baumann
Princess Margaret Cancer Centre, University Health Network

Creating a Positive QA Team Image and Strengthening the Auditor/Research Team Relationship [Abstract
C. Knoerle, J. Edwards, D. Jenkins, N. Wallace
Siteman Cancer Center

Deciding How to Decide: Let Your Values Be Your Guide [Abstract]
J. Edwards, C. Knoerle, D. Jenkins, N. Wallace
Siteman Cancer Center

Epic Transitions: How to Prepare Your Staff for Enterprise-Wide Change [Abstract]
E. Menne, K. Williams, E. Hawkins
Siteman Cancer Center

The Critical Need for Consistent Training for Clinical Research Professionals [Abstract]
K. Jelinek, R. Amoah
The Ohio State University Comprehensive Cancer Center, James Cancer Hospital & Solove Research Institute

Help is on the Way: A CTMS Training Solution at an NCI-Designated Cancer Center [Abstract]
M. Farris, J. de Jong
The University of Kansas Cancer Center

Peer-to-Peer Quality Chart Review [Abstract]
A. Skafel, P. Steiding, S. Barajas, A. Ferdinando
UCSF Helen Diller Family Comprehensive Cancer Center

Heat Mapping Noncompliance to Better Target the Extent of Corrective and Preventive Action Plans and Training [Abstract
J.K. Morrison, S. Scott
UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Educating the Next Generation of Clinical Researchers [Abstract]
A. Ivey, L. Pettiford, T. George
University of Florida Health Cancer Center

Evolving Recruitment Strategies through the Development of a Research Nurse Residency Program for New Graduates [Abstract
J. Feliu, D. Cline, B. Showalter
University of Texas MD Anderson Cancer Center

Winship Clinical Trials Office CRC/CRN and Data Manager Orientation Program [Abstract]
T. Kurilo
Winship Cancer Institute of Emory University

Back to top

Trial Recruitment and Disparities Research

Trial Recruitment & Disparities Research: How Multicenter Institutional Studies Can Improve Enrollment [Abstract
A. Bauchle, L. Sego, S. Edwards
Indiana University Melvin & Bren Simon Cancer Center

MNCCTN: Challenges to Opening a State-Wide Network and the Pathway to Success - A 2-Year Perspective [Abstract
M.L. Rahne, R. Leed, C. Stibbe, J. Alkire
Masonic Cancer Center, University of Minnesota

Planting a Seed: How Bringing Research to the Community Can Blossom Into Patients Making Informed Health Care Decisions and Participating in Clinical Trials [Abstract]
C. Moss, E. Meisler, K. Hunt, D. Allen, C. Hugney, S. Abraksia
The Cleveland Clinic Cancer Center

C3OD, An Abstraction and Recruitment Tool [Abstract]
D.P. Mudaranthakam, J. Thompson, D. Streeter
The University of Kansas Cancer Center

The Impact of Modifying Eligibility Criteria on Accrual to Cancer Clinical Trials [Abstract]
D.P. Mudaranthakam1, J. Thompson1, D. Streeter1, J. Unger2, M. Fleury3
1The University of Kansas Cancer Center; 2Fred Hutchinson Cancer Research Center; 3American Cancer Society Cancer Action Network

Enhancing Accruals via Automated Performance Monitoring [Abstract]
A. Ivey, T. George, A. Anderson, W.J. Stokes, H. Koranne
University of Florida Health Cancer Center

Back to top

Trial Startup/Closure

Clinical Trials Office New Study Committee: A Streamlined and Collaborative Approach for Clinical Trial Portfolio Management [Abstract]
K. Krul, S. Bigelow, M. Kelley, L. Lange
Barbara Ann Karmanos Cancer Institute, Wayne State University

The Need for Speed: Piloting a Study Activation Committee [Abstract
S. Flores, N. Sender, L. Blumberg, L. Segall, S. Mistretta, J. Wang, L. Butaud-Rebbaa, Q.-D. Quiles, T. Negri, M. Kelsen, F. Brogan, D. Otap, N. Rizzo
Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center

Improving Efficiency and Time Management During the Site Selection Process: A Collaborative Approach [Abstract]
L. Lujan, S. Sharry, J. Moehle, T. Werner, E. Constantz, J. Espinosa, S. Fairbairn, B. Johnson
Huntsman Cancer Institute, University of Utah

Interdisciplinary Approach to Research Biopsy Acquisition in Oncology Clinical Trials [Abstract]
K. Schroeder1, J. Roessler2, S. Zindars1, M. Rau1, E. Polak2, J. Fleischman1
1Medical College of Wisconsin Cancer Center; 2Froedtert Hospital

How Does a Master CDA Affect Timelines? [Abstract]
C. Mackay1, J. King2
1The University of Kansas Cancer Center; 2Covance

Value of Centralized Pre-Study Process [Abstract]
A. Roberts, S. Davidson, N. Streeter, C. Mackay
The University of Kansas Cancer Center

Enhancing the Voice of Clinical Research Staff in the Trial Feasibility Process [Abstract]
A. Daniels, A. Anderson, A. Ivey, T. George, L. Pettiford
University of Florida Health Cancer Center

Increasing Activation Transparency With Research Insights Dashboards [Abstract
E. Rocco, N. Licht, N. O'Dell, R. Arzoomanian, T. Johnson
Yale Cancer Center, Yale School of Medicine

Empowering Study Teams to Improve Clinical Trial Activation Timelines [Abstract]
E. Rocco, N. Licht, N. O'Dell, T. Johnson, R. Arzoomanian
Yale Cancer Center, Yale School of Medicine

Back to top

How are abstracts scored and selected for presentation?   
Abstracts are evaluated by at least two reviewers from the AACI CRI Steering Committee and/or CRI Education Committee using a peer-review process. Three abstracts will be chosen for oral presentation that address an issue that provides relevant solutions that can be shared or adapted by other AACI cancer centers.

When will applicants be notified of their review outcome?
Abstract applicants will be notified in June 2019. 

What is the size requirement for the poster?
Posters may not exceed 24” x 36” (portrait) or 36” x 24” (landscape). Larger posters cannot be displayed on the provided poster boards.

What format or program should I use to develop my poster?
You may format your poster using a program of your choice. PowerPoint templates are available in landscape and portrait format.

How will posters be displayed?
Standard foam boards, 24” x 36” (portrait) or 36” x 24” (landscape), will be provided. Posters will be secured to the boards using tacks or binder clips, provided on-site. Posters are to be hung by the presenting author on Tuesday, July 9 before 4:00 pm CT and not removed until Thursday, July 11 after 10:00 am CT.

Does AACI CRI require a hard copy of my poster?
A hard copy is not required. Any posters left at the end of the meeting will be discarded.

Do I need to submit an electronic copy of my poster?
Yes, an electronic version must be emailed to cri@aaci-cancer.org by 5:00 pm PT on Friday, June 21, 2019 to allow time to be included on the meeting website and to prepare meeting displays. Attendees enjoy viewing posters prior to the meeting. Please email a full-sized, 24” x 36” (portrait) or 36” x 24” (landscape), version of your poster.

Are poster handouts required?
Although not required, handouts are recommended. Past meeting attendees have indicated that handouts are helpful for facilitating a discussion of your poster at the poster session. We recommend printing 75 copies.

What happens to my abstract after the meeting?
Abstracts and posters are published in a book that is distributed at the AACI/CCAF Annual Meeting, which is attended by cancer center directors, administrators, and physician clinical leaders. By submitting an abstract and poster, you give AACI permission to publish these materials. Your abstract will also be available for review on the AACI CRI abstract/poster webpage for up to one year or until the next CRI Annual Meeting.
 

February 1, 2019
Abstract requirements available

March 1, 2019
Online submission tool opens

April 19, 2019 | 5:00 pm PT
Deadline to submit abstracts


Mid-June
Abstracts selected for oral presentation notifications sent to submitting authors

June 21, 2019
Deadline to submit an electronic copy of your poster to cri@aaci-cancer.org

July 9, 2019 | 4:00 pm CT
Authors/presenters hang posters on-site in designated room